off-the-shelf treatment
Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments
Anika Sharma
Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...
